IMMUCELL CORP /DE/ Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Immucell Corp /De/ quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Immucell Corp /De/ Other Assets, Noncurrent for the quarter ending September 30, 2024 was $28.9K, a 58.7% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $28.9K -$41.1K -58.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $37.7K -$44.8K -54.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $46.2K -$41.5K -47.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $57.7K -$13.9M Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $70K +$45.5K +185% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $82.5K +$58.7K +247% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $87.8K +$64.8K +282% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $14M* +$14M Dec 31, 2022 10-K 2024-04-01
Q3 2022 $24.6K -$2.03K -7.63% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $23.8K -$1.61K -6.33% Jun 30, 2022 10-Q/A 2022-11-21
Q1 2022 $23K -$387 -1.66% Mar 31, 2022 10-Q/A 2022-11-21
Q4 2021 $26.1K -$58 -0.22% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $26.6K +$1.33K +5.28% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $25.4K +$1.69K +7.12% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $23.4K +$1.24K +5.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $26.2K -$711 -2.65% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $25.3K -$3.98K -13.6% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $23.7K +$16.7K +240% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $22.1K +$17.8K +408% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $26.9K +$13.9K +108% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $29.2K -$183K -86.2% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $6.97K -$2.18K -23.8% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $4.36K -$1.47K -25.2% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $13K +$12K +1308% Dec 31, 2018 10-K 2020-03-27
Q3 2018 $212K +$177K +504% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $9.15K -$26K -74% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $5.83K -$28.4K -83% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $920 -$33.3K -97.3% Dec 31, 2017 10-K 2019-03-22
Q3 2017 $35.2K +$920 +2.69% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $35.2K Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $34.3K -$245K -87.7% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $34.3K +$34.3K Dec 31, 2016 10-K 2018-03-29
Q3 2016 $34.3K -$15.4K -30.9% Sep 30, 2016 10-Q 2016-11-10
Q1 2016 $280K +$261K +1435% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $0 -$18.9K -100% Dec 31, 2015 10-Q 2016-11-10
Q3 2015 $49.6K +$30K +153% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $17.5K +$5.1K +41.1% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $18.2K +$5.29K +41% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $18.9K +$5.29K +38.8% Dec 31, 2014 10-K 2016-03-25
Q3 2014 $19.6K +$5.49K +38.8% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $12.4K -$50.1K -80.2% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 $12.9K -$50.1K -79.5% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $13.6K -$50K -78.6% Dec 31, 2013 10-K 2015-03-26
Q3 2013 $14.2K -$2.6K -15.5% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $62.5K +$45.1K +260% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 $63K +$44.4K +239% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $63.6K +$44.6K +235% Dec 31, 2012 10-K 2014-03-26
Q3 2012 $16.8K -$2.98K -15.1% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $17.4K +$141 +0.82% Jun 30, 2012 10-Q/A 2012-09-07
Q1 2012 $18.6K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 $19K -$15K -44.1% Dec 31, 2011 10-K 2013-03-28
Q3 2011 $19.7K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $17.2K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $34K Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.